441 related articles for article (PubMed ID: 16012715)
41. Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma.
Hirayama N; Tabata C; Tabata R; Maeda R; Yasumitsu A; Yamada S; Kuribayashi K; Fukuoka K; Nakano T
Respir Med; 2011 Jan; 105(1):137-42. PubMed ID: 21041073
[TBL] [Abstract][Full Text] [Related]
42. [Malignant mesothelioma: prognostic factors in a series of 125 patients studied from 1973 to 1987].
Boutin C; Rey F; Gouvernet J
Bull Acad Natl Med; 1992 Jan; 176(1):105-14; discussion 115-7. PubMed ID: 1606507
[TBL] [Abstract][Full Text] [Related]
43. Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma.
Davidson B; Reich R; Lazarovici P; Flørenes VA; Risberg B; Nielsen S; Sert B; Bedrossian C
Lung Cancer; 2004 May; 44(2):159-65. PubMed ID: 15084380
[TBL] [Abstract][Full Text] [Related]
44. Establishment of three novel human malignant pleural mesothelioma cell lines: morphological and cytogenetical studies and EGFR mutation status.
Kobayashi M; Takeuchi T; Ohtsuki Y
Anticancer Res; 2008; 28(1A):197-208. PubMed ID: 18383846
[TBL] [Abstract][Full Text] [Related]
45. The role of cytological evaluation of pleural fluid in diagnosing malignant mesothelioma.
Lovrenski A; Panjković M; Tegeltija D; Latinović LT; Krcedinac J
Med Pregl; 2012; 65(1-2):5-8. PubMed ID: 22452231
[TBL] [Abstract][Full Text] [Related]
46. Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy.
Arrossi AV; Lin E; Rice D; Moran CA
Am J Clin Pathol; 2008 Nov; 130(5):754-64. PubMed ID: 18854268
[TBL] [Abstract][Full Text] [Related]
47. Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.
Bottomley A; Coens C; Efficace F; Gaafar R; Manegold C; Burgers S; Vincent M; Legrand C; van Meerbeeck JP;
J Clin Oncol; 2007 Dec; 25(36):5770-6. PubMed ID: 18089874
[TBL] [Abstract][Full Text] [Related]
48. Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma.
Kadota K; Villena-Vargas J; Nitadori J; Sima CS; Jones DR; Travis WD; Adusumilli PS
Ann Surg Oncol; 2015 Sep; 22(9):3136-43. PubMed ID: 25608772
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
[TBL] [Abstract][Full Text] [Related]
50. Diagnosis and prognosis in malignant pleural mesothelioma: a prospective study.
Mårtensson G; Hagmar B; Zettergren L
Eur J Respir Dis; 1984 Apr; 65(3):169-78. PubMed ID: 6723826
[TBL] [Abstract][Full Text] [Related]
51. Malignant pleural mesothelioma: clinicopathology of 16 extrapleural pneumonectomy patients with special reference to early stage features.
Hiroshima K; Yusa T; Kameya T; Ito I; Kaneko K; Kadoyama C; Kishi H; Saitoh Y; Ozaki D; Itami M; Iwata T; Iyoda A; Kawai T; Yoshino I; Nakatani Y
Pathol Int; 2009 Aug; 59(8):537-45. PubMed ID: 19627537
[TBL] [Abstract][Full Text] [Related]
52. Well-differentiated papillary mesothelioma with invasion to the chest wall.
Torii I; Hashimoto M; Terada T; Kondo N; Fushimi H; Shimazu K; Takeda S; Takuwa T; Okumura Y; Sato A; Yamamoto T; Fukuoka K; Tanaka F; Nishigami T; Nakano T; Hasegawa S; Tsujimura T
Lung Cancer; 2010 Feb; 67(2):244-7. PubMed ID: 19880210
[TBL] [Abstract][Full Text] [Related]
53. Localised malignant pleural mesothelioma: a separate clinical entity requiring aggressive local surgery.
Nakas A; Martin-Ucar AE; Edwards JG; Waller DA
Eur J Cardiothorac Surg; 2008 Feb; 33(2):303-6. PubMed ID: 18155556
[TBL] [Abstract][Full Text] [Related]
54. Pleural malignant mesothelioma with invasive micropapillary component and its association with pulmonary metastasis.
Mogi A; Nabeshima K; Hamasaki M; Uesugi N; Tamura K; Iwasaki A; Shirakusa T; Iwasaki H
Pathol Int; 2009 Dec; 59(12):874-9. PubMed ID: 20021613
[TBL] [Abstract][Full Text] [Related]
55. Lymphohistiocytoid variant of malignant mesothelioma of the pleura: a series of 22 cases.
Galateau-Sallé F; Attanoos R; Gibbs AR; Burke L; Astoul P; Rolland P; Ilg AG; Pairon JC; Brochard P; Begueret H; Vignaud JM; Kerr K; Launoy G; Imbernon E; Goldberg M
Am J Surg Pathol; 2007 May; 31(5):711-6. PubMed ID: 17460454
[TBL] [Abstract][Full Text] [Related]
56. [Diffuse malignant pleural mesothelioma].
Katsuragi N; Shiraishi Y; Kita H; Toishi M; Miyasaka Y; Tanaka S
Kyobu Geka; 2007 Jan; 60(1):35-9. PubMed ID: 17249536
[TBL] [Abstract][Full Text] [Related]
57. Expression of RCAS1 and its function in human squamous cell carcinoma of the oral cavity.
Fukuda M; Tanaka A; Hamao A; Suzuki S; Kusama K; Sakashita H
Oncol Rep; 2004 Aug; 12(2):259-67. PubMed ID: 15254686
[TBL] [Abstract][Full Text] [Related]
58. Prognostic factors and survival in malignant pleural mesothelioma.
Van Gelder T; Damhuis RA; Hoogsteden HC
Eur Respir J; 1994 Jun; 7(6):1035-8. PubMed ID: 7925870
[TBL] [Abstract][Full Text] [Related]
59. Advances in the biology of malignant pleural mesothelioma.
Zucali PA; Ceresoli GL; De Vincenzo F; Simonelli M; Lorenzi E; Gianoncelli L; Santoro A
Cancer Treat Rev; 2011 Nov; 37(7):543-58. PubMed ID: 21288646
[TBL] [Abstract][Full Text] [Related]
60. Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma.
Burt BM; Rodig SJ; Tilleman TR; Elbardissi AW; Bueno R; Sugarbaker DJ
Cancer; 2011 Nov; 117(22):5234-44. PubMed ID: 21523763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
